We previously demonstrated that TTI-101 targets STAT1, in addition to STAT3, in human radioresistant head and neck squamous cell carcinoma cell lines [11] and that it also targets STAT5 in a mouse model of increased breast cancer risk caused by pregnancy [52]. Here, STAT1 is linked to breast cancer.